nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—DDC—Parkinson's disease	0.829	1	CbGaD
Cycloserine—DDC—Catecholamine biosynthesis—DBH—Parkinson's disease	0.0136	0.0985	CbGpPWpGaD
Cycloserine—DDC—telencephalic ventricle—Parkinson's disease	0.00878	0.275	CbGeAlD
Cycloserine—DDC—Dopaminergic Neurogenesis—PITX3—Parkinson's disease	0.00736	0.0531	CbGpPWpGaD
Cycloserine—DDC—Catecholamine biosynthesis—TH—Parkinson's disease	0.00559	0.0403	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—LMX1A—Parkinson's disease	0.00558	0.0402	CbGpPWpGaD
Cycloserine—DDC—nerve—Parkinson's disease	0.00553	0.173	CbGeAlD
Cycloserine—DDC—Biogenic Amine Synthesis—DBH—Parkinson's disease	0.00474	0.0342	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—SEPT5—Parkinson's disease	0.00462	0.0333	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—PINK1—Parkinson's disease	0.00462	0.0333	CbGpPWpGaD
Cycloserine—DDC—Amine-derived hormones—DBH—Parkinson's disease	0.0045	0.0325	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—EN1—Parkinson's disease	0.00423	0.0305	CbGpPWpGaD
Cycloserine—DDC—hindbrain—Parkinson's disease	0.00414	0.13	CbGeAlD
Cycloserine—DDC—Parkinsons Disease Pathway—SNCAIP—Parkinson's disease	0.00392	0.0283	CbGpPWpGaD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—PPP1R1B—Parkinson's disease	0.0039	0.0281	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—HTRA2—Parkinson's disease	0.0035	0.0252	CbGpPWpGaD
Cycloserine—DDC—Dopamine metabolism—MAOB—Parkinson's disease	0.00328	0.0237	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—ATXN2—Parkinson's disease	0.00297	0.0215	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—NR4A2—Parkinson's disease	0.00272	0.0196	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—GPR37—Parkinson's disease	0.00265	0.0191	CbGpPWpGaD
Cycloserine—DDC—embryo—Parkinson's disease	0.00259	0.0812	CbGeAlD
Cycloserine—DDC—brainstem—Parkinson's disease	0.00238	0.0744	CbGeAlD
Cycloserine—DDC—forebrain—Parkinson's disease	0.00229	0.0718	CbGeAlD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—SLC18A2—Parkinson's disease	0.00226	0.0163	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—PARK7—Parkinson's disease	0.00225	0.0163	CbGpPWpGaD
Cycloserine—DDC—Dopamine metabolism—NQO1—Parkinson's disease	0.00221	0.0159	CbGpPWpGaD
Cycloserine—DDC—Dopamine metabolism—TH—Parkinson's disease	0.00218	0.0157	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—UCHL1—Parkinson's disease	0.00206	0.0149	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—LRRK2—Parkinson's disease	0.00201	0.0145	CbGpPWpGaD
Cycloserine—DDC—Biogenic Amine Synthesis—TH—Parkinson's disease	0.00194	0.014	CbGpPWpGaD
Cycloserine—DDC—Dopamine metabolism—SOD1—Parkinson's disease	0.00189	0.0136	CbGpPWpGaD
Cycloserine—DDC—Dopamine metabolism—COMT—Parkinson's disease	0.00185	0.0133	CbGpPWpGaD
Cycloserine—DDC—Amine-derived hormones—TH—Parkinson's disease	0.00184	0.0133	CbGpPWpGaD
Cycloserine—DDC—Dopamine metabolism—MAOA—Parkinson's disease	0.00184	0.0133	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—SNCA—Parkinson's disease	0.0018	0.013	CbGpPWpGaD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—CHRNA4—Parkinson's disease	0.00179	0.0129	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—SLC18A2—Parkinson's disease	0.0017	0.0123	CbGpPWpGaD
Cycloserine—DDC—Biogenic Amine Synthesis—COMT—Parkinson's disease	0.00165	0.0119	CbGpPWpGaD
Cycloserine—DDC—Biogenic Amine Synthesis—MAOA—Parkinson's disease	0.00164	0.0118	CbGpPWpGaD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—DRD3—Parkinson's disease	0.00161	0.0116	CbGpPWpGaD
Cycloserine—DDC—midbrain—Parkinson's disease	0.00151	0.0474	CbGeAlD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—TH—Parkinson's disease	0.00148	0.0107	CbGpPWpGaD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—DRD2—Parkinson's disease	0.00146	0.0105	CbGpPWpGaD
Cycloserine—DDC—head—Parkinson's disease	0.00131	0.0411	CbGeAlD
Cycloserine—DDC—Parkinsons Disease Pathway—PARK2—Parkinson's disease	0.00128	0.00926	CbGpPWpGaD
Cycloserine—DDC—nervous system—Parkinson's disease	0.00124	0.039	CbGeAlD
Cycloserine—DDC—central nervous system—Parkinson's disease	0.0012	0.0375	CbGeAlD
Cycloserine—DDC—Tryptophan metabolism—MAOB—Parkinson's disease	0.0012	0.00862	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00113	0.00815	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—TH—Parkinson's disease	0.00111	0.00804	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—SLC6A3—Parkinson's disease	0.00111	0.00804	CbGpPWpGaD
Cycloserine—DDC—brain—Parkinson's disease	0.000951	0.0298	CbGeAlD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000945	0.00682	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—SLC6A3—Parkinson's disease	0.000922	0.00665	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—TH—Parkinson's disease	0.000922	0.00665	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000905	0.00653	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000905	0.00653	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—CYCS—Parkinson's disease	0.000886	0.00639	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00087	0.00628	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.000856	0.00618	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—MCCC1—Parkinson's disease	0.000828	0.00597	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000812	0.00586	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—DBH—Parkinson's disease	0.000627	0.00452	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00062	0.00447	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00048	0.00347	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000442	0.00319	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—CASP3—Parkinson's disease	0.000375	0.00271	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00036	0.00259	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000346	0.0025	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000341	0.00246	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.000326	0.00235	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000315	0.00227	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000302	0.00218	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000298	0.00215	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—DRD1—Parkinson's disease	0.000273	0.00197	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—DRD3—Parkinson's disease	0.000264	0.00191	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000263	0.0019	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—NQO1—Parkinson's disease	0.00026	0.00188	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—TH—Parkinson's disease	0.000257	0.00185	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000252	0.00182	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000252	0.00182	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—TH—Parkinson's disease	0.000243	0.00176	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000243	0.00175	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—DRD2—Parkinson's disease	0.000239	0.00172	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—HTR7—Parkinson's disease	0.000239	0.00172	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000215	0.00155	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000205	0.00148	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ND3—Parkinson's disease	0.000152	0.0011	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MCCC1—Parkinson's disease	0.000152	0.0011	CbGpPWpGaD
Cycloserine—DDC—Metabolism—OMD—Parkinson's disease	0.000143	0.00103	CbGpPWpGaD
Cycloserine—DDC—Metabolism—TALDO1—Parkinson's disease	0.000143	0.00103	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NDUFB11—Parkinson's disease	0.000135	0.000977	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GCH1—Parkinson's disease	0.000129	0.000932	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000122	0.000877	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000121	0.000875	CbGpPWpGaD
Cycloserine—DDC—Metabolism—DBH—Parkinson's disease	0.000115	0.000831	CbGpPWpGaD
Cycloserine—DDC—Metabolism—FBP1—Parkinson's disease	0.000115	0.000831	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GBA—Parkinson's disease	0.000115	0.000831	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—MAPK8—Parkinson's disease	9.1e-05	0.000657	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TNF—Parkinson's disease	8.82e-05	0.000636	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTA4—Parkinson's disease	7.98e-05	0.000576	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLA2G6—Parkinson's disease	7.19e-05	0.000519	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL6—Parkinson's disease	7.12e-05	0.000513	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MAOB—Parkinson's disease	7.12e-05	0.000513	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—IL6—Parkinson's disease	5.81e-05	0.000419	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP2D6—Parkinson's disease	5.29e-05	0.000381	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CTGF—Parkinson's disease	5.19e-05	0.000374	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP2E1—Parkinson's disease	4.84e-05	0.000349	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NQO1—Parkinson's disease	4.78e-05	0.000345	CbGpPWpGaD
Cycloserine—DDC—Metabolism—TH—Parkinson's disease	4.71e-05	0.00034	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYCS—Parkinson's disease	4.53e-05	0.000326	CbGpPWpGaD
Cycloserine—DDC—Metabolism—COMT—Parkinson's disease	4.01e-05	0.000289	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTP1—Parkinson's disease	3.99e-05	0.000288	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MAOA—Parkinson's disease	3.98e-05	0.000287	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HMOX1—Parkinson's disease	3.93e-05	0.000284	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCB1—Parkinson's disease	3.78e-05	0.000272	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTM1—Parkinson's disease	3.67e-05	0.000264	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GPX1—Parkinson's disease	3.51e-05	0.000253	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MTHFR—Parkinson's disease	3.24e-05	0.000234	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOE—Parkinson's disease	3.02e-05	0.000218	CbGpPWpGaD
Cycloserine—DDC—Metabolism—INS—Parkinson's disease	2.58e-05	0.000186	CbGpPWpGaD
